Keros Therapeutics, Inc.

Insider purchase · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.
Event type
insider.buy
Occurred
2026-08-17
Reported
2026-08-19
Disclosure lag
2 days

Context

links are based on the recorded entity type
FieldRecorded value
EntityKeros Therapeutics, Inc.
SourceSEC EDGAR ↗
News sectioncompanies
Source identifier0001221590-26-000025
Source-linked related entitiesbienaime-jean-jacques-1221590 · person
Event ID#876282

Related recorded events

same canonical or source-linked entity relations
ReportedTypeEventSource
2026-09-29New filingEvent #1193901SEC EDGAR
2026-09-08New filingEvent #1099464SEC EDGAR
2026-08-20Insider saleEvent #895755SEC EDGAR
2026-08-03New filingEvent #279318SEC EDGAR
2026-08-03New filingEvent #279317SEC EDGAR
2026-08-03New filingEvent #278907SEC EDGAR
2026-07-30New filingEvent #170341SEC EDGAR
2026-07-22New filingEvent #20093SEC EDGAR

Recorded payload

JSON payload as stored after parsing
{
  "accession": "0001221590-26-000025",
  "acquired_disposed": "A",
  "code": "P",
  "direct_or_indirect": "D",
  "form": "4",
  "is_derivative": false,
  "issuer_name": "Keros Therapeutics, Inc.",
  "label": "Open market purchase",
  "person_name": "BIENAIME JEAN JACQUES",
  "price": 10.27,
  "role": "Director",
  "security": "Common Stock",
  "shares": 1000,
  "shares_owned_after": 19592,
  "source_path": "edgar/data/1221590/0001221590-26-000025.txt",
  "ticker": "KROS",
  "transaction_date": "2026-08-17",
  "value": 10270
}

Evidence-based analysis

facts, provenance and explicit model coverage
Descriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.
DimensionStatus / valueMethod or boundary
What happenednot_coveredThe source record has no short title or summary.
Whensource_backed · reported 2026-08-19Occurred 2026-08-17. Source-record timestamps; no timezone or event time is inferred.
Affected entitiesresolved · Keros Therapeutics, Inc. · 1 relatedCanonical primary entity and stored related_entity_ids only.
Event classificationinsider · insider.buycanonical event type plus source-provided category; no sentiment or impact is inferred
Entity linkingresolvedCanonical entity resolved during ingestion
Deduplicationappliedunique source event key at ingestion
Source trusthigh · terms allowedSource registry metadata
Sentimentnot_coveredNo sentiment model output is published for this record.
Market reactionnot_coveredRequires licensed quote, candle and volume observations for the affected instrument.
Historical analogsnot_coveredRequires an audited event-cluster corpus and matching methodology.
Impact mechanismnot_coveredNo causal market-impact model is published for this record.
Related risksnot_coveredRisk implications require an audited instrument/entity exposure model.
Instrument linkagenot_coveredNo instrument relation is inferred from an entity event; licensed instrument mapping is required.

Source: Open recorded SEC filing

Source: SEC EDGAR · as of 2026-08-19T00:00:00Z

Keros Therapeutics, Inc. — recorded event — investment.com